News

Clarient and BioView have reported that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung

Elan Drug Technologies, a business unit of Elan, receives approval from the Japanese Ministry of Health, Labour and Welfare for Emend (aprepitant) for the treatment of cancer chemotherapy-induced

Rexahn Pharmaceuticals (Rexahn) and TheraTarget have entered into a joint research collaboration agreement. As per the terms of the agreement, TheraTarget is expected to synthesize and supply Rexahn

Sanofi-aventis and its wholly-owned subsidiary, BiPar Sciences, have announced that the clinical development program in metastatic triple-negative breast cancer (mTNBC) for the investigational PARP1 inhibitor, BSI-201, progresses as

Eli Lilly has reported that the FDA has approved Zyprexa Relprevv (Olanzapine) for extended release injectable suspension for the treatment of schizophrenia in adults. Zyprexa Relprevv, a long-acting

Icon has expanded its European central laboratory, located in South County Business Park, Dublin. The newly-designed 41,000sft (3,800m²) facility, which is three times the size of the previous

Sigma Pharmaceuticals (Sigma) and Neurim Pharmaceuticals (Neurim) have entered into a Licensing Agreement for Circadin, a prolonged release melatonin for primary insomnia, in Australia. Circadin, currently approved for

Instem has established an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences

LyondellBasell Industries has launched a new low density polyethylene (LDPE) resin for use in injection molding and masterbatch applications. The new Lupolen 1800U grade features a balance of